Canada: The Canadian Special Access Program For Medical Devices

Last Updated: July 15 2013
Article by Lydia Wakulowsky and Ratika Gandhi

Health Canada regulates the safety, efficacy and quality of therapeutic products, including medical devices under the Food and Drugs Act. Before a medical device receives market authorization from Health Canada, access is usually limited to investigational testing involving human subjects, which is sponsored by a manufacturer and authorized by Health Canada through an investigational testing application. When an unlicensed medical device is not available in Canada through enrolment in investigational testing, Health Canada may authorize a health care professional's access to the device through its Special Access Program. This bulletin describes Canada's Special Access Program for medical devices, which is governed by Part 2 of the Medical Devices Regulations made under the Food and Drugs Act.

The Program

Class III or IV custom-made devices and Class II, III or IV medical devices that have not been approved for use in Canada require special access authorization from the Medical Devices Bureau of Health Canada before being imported or sold in Canada. A "custom-made device" is "a medical device, other than a mass-produced medical device, that: (a) is manufactured in accordance with a health care professional's written direction giving its design characteristics; (b) differs from medical devices generally available for sale or from a dispenser; and (c) is (i) for the sole use of a particular patient of that professional, or (ii) for use by that professional to meet special needs arising in the course of his or her practice". Special access authorization is not required for the importation and sale of Class I and II custom-made devices; however, the special access labelling requirements must still be observed.

Canada's Special Access Program allows health care professionals to gain access to Class III or IV custom-made devices and Class II, III or IV medical devices that have not been approved for use in Canada on a narrow and discretionary basis. Health care professionals may access such devices for emergency use or if conventional therapies have failed, are unavailable, or are unsuitable to provide a diagnosis, treatment or prevention for patients under their care. "Health care professional" is defined as "a person who is entitled under the laws of a province to provide health services in the province". This broad definition enables a wide scope professionals to request a medical device for special access − not just physicians.

Application For Authorization

A health care professional is responsible for submitting a complete application for authorization to Health Canada under the Special Access Program. The information to be submitted includes, among other things:

  • information about the device and its manufacturer or importer,
  • the medical rationale for the use of the device, including:

    • the diagnosis, treatment or prevention for which the unlicensed device is required,
    • a list of the licensed devices available for sale in Canada that were considered and a rationale as to why they would not adequately meet the requirements of the patient,
    • the reasons the unlicensed device was chosen for the diagnosis, treatment or prevention,
    • the risks and benefits associated with the use of the unlicensed device,
    • the known safety and effectiveness information in respect of the device, and
    • in the case of a request for a batch release, a description of the emergency condition requiring treatment, and the number of devices required for one month (a batch release authorization can be issued for a one-month supply to devices to treat patients on an urgent basis if shipping delays would result in adverse patient outcomes),
  • the name and address of each health care facility at which the device is to be used by the health care professional and to which the device is to be shipped, and
  • a written undertaking by the health care professional that the professional will inform the patient for whom the device is intended of the risks and benefits associated with its use.

While Health Canada's regulatory authority under the Special Access Program is discretionary Health Canada must issue an authorization to a manufacturer or importer if it determines that:

  • the benefits that may be obtained by the patient through the use of the device outweigh the risks associated with its use,
  • the health or safety of patients, users or other persons will not be unduly affected,
  • a licensed device that would adequately meet the requirements of the patient is not available in Canada, and
  • the authorization is not being used by the manufacturer or importer to circumvent the requirements of Part 1 of the Medical Devices Regulations.

Health Canada provides a decision within three working days for non-emergency requests, and the same day for emergency requests. Health Canada also has the discretion to cancel an authorization after it has been issued.

Issues For Consideration

In considering the special access request, Health Canada does not conduct a comprehensive evaluation on the validity of medical device information or assertions from the manufacturer with respect to safety, efficacy and quality. Therefore, the authorization given for any medical device does not constitute an opinion that it is safe or efficacious. Health care professionals must ensure their decision to recommend the unlicensed medical device is made after an appropriate risk/benefit analysis in the best interests of the patient and is supported by credible evidence found in the medical literature or provided by the manufacturer. Further, as is the case for any treatment, the health care professional must obtain the patient's informed consent to the use of the medical device.

A health care professional must within 72 hours after the occurrence of any incident that comes to his or her attention occurring inside Canada and involving a medical device for which a special access authorization has been issued and that:

  • is related to a failure of the device or a deterioration in its effectiveness, or any inadequacy in its labelling or in the directions for use, and
  • has led to the death or a serious deterioration in the state of health of a patient, user or other person, or could do so were it to recur,

report the incident to Health Canada and to the manufacturer or importer of the device, and specify the nature of the incident and the circumstances surrounding it.

This mandatory problem reporting requirement applies to incidents occurring outside Canada if the manufacturer has indicated, to a regulatory agency of the country in which the incident occurred, the manufacturer's intention to take corrective action, or if the regulatory agency has required the manufacturer to take corrective action.

A manufacturer or importer must ensure the unlicensed device is labelled with the name of the device and manufacturer, and whether the device is custom-made or imported or sold for special access, and maintain a distribution record for the device in accordance with sections 52 through 56 of the Medical Device Regulations. The implant registration requirements of sections 66 to 68 of the Medical Devices Regulations apply in respect of an implant that is imported or sold for special access.

The Special Access Program is responsible only for permitting the import and sale of a medical device to a health care professional. Funding for the delivery of health care is under provincial jurisdiction. Patients will need to determine if the costs of the medical device will be funded by the province, by a private insurer or by the patients themselves.

Health Canada has stated that the Special Access Program is not intended to promote the early use of medical devices and should not be used to circumvent the regulatory review and authorization process for new medical devices in Canada. Because only health care professionals can initiate access requests, it cannot and should not be used by manufacturers or importers to achieve this result.

A manufacturer or importer that advises health care professionals that its medical devices are available by special access may be exposing itself to regulatory action by Health Canada. The Food and Drugs Act provides that no person shall advertise any medical device in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding the medical device's design, construction, performance, intended use, quantity, character, value, composition, merit or safety. A Class II, III or IV medical device cannot be advertised for the purpose of sale before the medical device has been licensed by Health Canada. An exception to this advertising prohibition is available if the advertisement is placed only in a catalogue accompanied by a clear and visible warning that the advertised medical device may not have been licensed in accordance with Canadian law.

Manufacturers and importers might be tempted to view the Special Access Program as a means to market unlicensed medical devices in Canada. Given the strict conditions of the Special Access Program that must be fulfilled before access is authorized, it is not a viable way to circumvent the regulatory review and approval process. However, in situations where health care professionals believe that access to these unlicensed medical devices is beneficial, the Special Access Program could potentially provide promising alternatives for patients who may otherwise be precluded from benefitting from certain devices.

The foregoing provides only an overview. Readers are cautioned against making any decisions based on this material alone. Rather, a qualified lawyer should be consulted.

© Copyright 2013 McMillan LLP

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Lydia Wakulowsky
Ratika Gandhi
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.